These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9045716)

  • 1. Low density lipoprotein receptor-related protein modulates the expression of tissue-type plasminogen activator in human colon fibroblasts.
    Hardy MM; Feder J; Wolfe RA; Bu G
    J Biol Chem; 1997 Mar; 272(10):6812-7. PubMed ID: 9045716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-mediated endocytosis of tissue-type plasminogen activator by low density lipoprotein receptor-related protein on human hepatoma HepG2 cells.
    Bu G; Maksymovitch EA; Schwartz AL
    J Biol Chem; 1993 Jun; 268(17):13002-9. PubMed ID: 8389767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
    Sitter T; Toet K; Quax P; Kooistra T
    Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
    Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
    Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of ligand binding to the second cluster of complement-type repeats of the low density lipoprotein receptor-related protein. Evidence for an allosteric component in receptor-associated protein-mediated inhibition of ligand binding.
    Horn IR; van den Berg BM; van der Meijden PZ; Pannekoek H; van Zonneveld AJ
    J Biol Chem; 1997 May; 272(21):13608-13. PubMed ID: 9153209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low density lipoprotein receptor-related protein is necessary for the internalization of both tissue-type plasminogen activator-inhibitor complexes and free tissue-type plasminogen activator.
    Orth K; Willnow T; Herz J; Gething MJ; Sambrook J
    J Biol Chem; 1994 Aug; 269(33):21117-22. PubMed ID: 8063731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of a 39 kDa protein with the low-density-lipoprotein-receptor-related protein (LRP) on rat hepatoma cells.
    Iadonato SP; Bu G; Maksymovitch EA; Schwartz AL
    Biochem J; 1993 Dec; 296 ( Pt 3)(Pt 3):867-75. PubMed ID: 8280086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of binding and internalization of tissue-type plasminogen activator by human vascular smooth muscle and endothelial cells.
    Grobmyer SR; Kuo A; Orishimo M; Okada SS; Cines DB; Barnathan ES
    J Biol Chem; 1993 Jun; 268(18):13291-300. PubMed ID: 7685759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the binding of pro-urokinase and urokinase-plasminogen activator inhibitor-1 complex to the low density lipoprotein receptor-related protein using a Fab fragment selected from a phage-displayed Fab library.
    Horn IR; Moestrup SK; van den Berg BM; Pannekoek H; Nielsen MS; van Zonneveld AJ
    J Biol Chem; 1995 May; 270(20):11770-5. PubMed ID: 7538122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes.
    Andreasen PA; Sottrup-Jensen L; Kjøller L; Nykjaer A; Moestrup SK; Petersen CM; Gliemann J
    FEBS Lett; 1994 Feb; 338(3):239-45. PubMed ID: 8307187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator.
    Bu G; Williams S; Strickland DK; Schwartz AL
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7427-31. PubMed ID: 1502154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the effect of fucosylated and non-fucosylated finger/growth-factor constructs on the clearance of tissue-type plasminogen activator mediated by the low-density-lipoprotein-receptor-related protein.
    Camani C; Gavin O; Bertossa C; Samatani E; Kruithof EK
    Eur J Biochem; 1998 Feb; 251(3):804-11. PubMed ID: 9490055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor?
    Camani C; Gavin O; Kruithof EK
    Thromb Haemost; 2000 Feb; 83(2):290-6. PubMed ID: 10739388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of tissue-type plasminogen activator by human monocyte-derived macrophages is mediated by the mannose receptor and by the low-density lipoprotein receptor-related protein.
    Noorman F; Braat EA; Rijken DC
    Blood; 1995 Nov; 86(9):3421-7. PubMed ID: 7579446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy zone protein-tissue-type plasminogen activator complexes bind to low-density lipoprotein receptor-related protein (LRP).
    Sánchez MC; Chiabrando GA; Vides MA
    Arch Biochem Biophys; 2001 May; 389(2):218-22. PubMed ID: 11339811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-1 and vitronectin promote the cellular clearance of thrombin by low density lipoprotein receptor-related proteins 1 and 2.
    Stefansson S; Lawrence DA; Argraves WS
    J Biol Chem; 1996 Apr; 271(14):8215-20. PubMed ID: 8626514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated transfer of the 39 kD receptor-associated protein increases fibrinolytic capacity.
    Goedde MF; Grimbergen JM; Toet KH; Sitter T; Quax PH; Kooistra T
    Kidney Int; 2001 Jul; 60(1):117-25. PubMed ID: 11422743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor.
    Rodenburg KW; Kjoller L; Petersen HH; Andreasen PA
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):55-63. PubMed ID: 9405275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo.
    Narita M; Bu G; Herz J; Schwartz AL
    J Clin Invest; 1995 Aug; 96(2):1164-8. PubMed ID: 7635954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, plasminogen activator inhibitor-1 and urokinase-plasminogen activator inhibitor-1 complex.
    Stefansson S; Kounnas MZ; Henkin J; Mallampalli RK; Chappell DA; Strickland DK; Argraves WS
    J Cell Sci; 1995 Jun; 108 ( Pt 6)():2361-8. PubMed ID: 7673355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.